Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11414416 Compounds and uses thereof

Patent 11414416 was granted and assigned to Foghorn Therapeutics on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851445 Compounds and uses thereof
0
Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11787800 BRD9 degraders and uses thereof
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Jason T. Lowe0
Johannes H. Voigt0
Matthew Netherton0
Sabine K. Ruppel0
Zhaoxia Yang0
Edits on 27 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11767330 Citrate salt, pharmaceutical compositions, and methods of making and using the same
Edits on 6 Aug, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Aug, 2023
Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11691972 Compounds for targeted degradation of BRD9
0
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Foghorn Therapeutics
Foghorn Therapeutics
0
Current Assignee
Foghorn Therapeutics
Foghorn Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114144160
Date of Patent
August 16, 2022
0
Patent Application Number
174785050
Date Filed
September 17, 2021
0
Patent Citations
‌
US Patent 11185592 Spirocyclic degronimers for target protein degradation
0
‌
US Patent 10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
0
‌
US Patent 10646575 Heterocyclic degronimers for target protein degradation
0
‌
US Patent 10660968 Spirocyclic degronimers for target protein degradation
0
‌
US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
0
‌
US Patent 10905768 Heterocyclic degronimers for target protein degradation
0
Patent Primary Examiner
‌
Niloofar Rahmani
0
CPC Code
‌
C07D 471/04
0
‌
C07D 401/14
0
‌
C07D 519/00
0
‌
C07D 498/10
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 17 Aug, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 17 Aug, 2022
Edits made to:
Infobox (+19 properties)
Article (+139 characters)
‌

 US Patent 11414416 Compounds and uses thereof

Article

The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.

Infobox
Is a
Patent
Patent
Patent Applicant
Foghorn Therapeutics
Foghorn Therapeutics
Current Assignee
Foghorn Therapeutics
Foghorn Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11414416
Date of Patent
August 16, 2022
Patent Application Number
17478505
Date Filed
September 17, 2021
Patent Citations
‌
US Patent 11185592 Spirocyclic degronimers for target protein degradation
‌
US Patent 10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
‌
US Patent 10646575 Heterocyclic degronimers for target protein degradation
‌
US Patent 10660968 Spirocyclic degronimers for target protein degradation
‌
US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
‌
US Patent 10905768 Heterocyclic degronimers for target protein degradation
Patent Primary Examiner
‌
Niloofar Rahmani
CPC Code
‌
C07D 471/04
‌
C07D 401/14
‌
C07D 519/00
‌
C07D 498/10

Find more entities like US Patent 11414416 Compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo